 STAT6 interacts PPARgamma elicit macrophage polarization towards anti-inflammatory, insulin-sensitizing phenotype. Mice deficient STAT6 display liver lipid accumulation (hepatosteatosis). Rosiglitazone (RSG), PPARgamma agonist, ameliorates hepatosteatosis enhances insulin sensitivity. elucidate role STAT6 PPARgamma action hepatosteatosis compared liver proteomes RSG-treated wild type STAT6-deficient mice identified pyruvate kinase M2 (PKM2), glycolysis proliferation-regulating enzyme displayed STAT6-dependent expression. RSG induced PKM2 within inflammatory cells liver suppressed expression adipose tissue. RSG diminished hepatosteatosis oxidative stress, enhanced fat accumulation improved insulin sensitivity STAT6-deficient mice. data reveal complex interaction STAT6 PPARgamma regulation liver adipose tissue lipid depot distribution design STAT6 novel link inflammatory cell metabolism adipocyte hepatocyte function.